GlaxoSmithKline Consumer Healthcare Ltd on Thursday reported 43.17 per cent increase rise in net profit to Rs 2.7549 billion for the second quarter ended September 30.
The company had posted a net profit of Rs 1.9241 billion in the July-September quarter a year ago, GlaxoSmithKline Consumer Healthcare said in a filing to BSE.
Its net sales was up 14.41 per cent to Rs 12.7199 billion during the quarter under review as against Rs 11.1171 billion in the corresponding quarter of the previous fiscal.
The company's total expenses was up 7.18 per cent at Rs 9.3358 billion compared to Rs 8.7102 billion.
Shares of GlaxoSmithKline Consumer Healthcare on Thursday closed at Rs 7,074.55 on BSE, up 0.80 per cent from previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)